120 likes | 131 Views
The global Next Generation Sequencing Market is expected to reach USD 23.59 Billion by 2027, according to a new report by Emergen Research. The benefits of high-performance sequencing compared to other generations, such as the sanger-seq and microarrays, are one of the main drivers of the Next Generation Sequencing (NGS) industry. Therefore, it is expected that the increased availability of low input DNA sampling methods would speed up the use of next-generation sequence across various clinical and research applications.
E N D
Next-Generation Sequencing Market Size Worth USD 23.59 Billion By 2027 Increasing evolution and decline in costs of NGS platforms and the development of the NGS diagnostic test regulatory and reimbursement scenarios are driving the demand for the market. www.emergenresearch.com
Our Model Market Analysis Financial Analysis Distribution Channel Analysis Brand Analysis Custom Market Intelligence Competitor Analysis Product Analysis Custom Research www.emergenresearch.com Demand Analysis Risk Analysis
Business Plan Parameters End Use Analysis Demand Availability Analytics Market Entry Strategy Restructuring & Revival New Product Strategy Product Planning / Strategy SWOT Analysis Marketing / Distribution Channel Feasibility www.emergenresearch.com Customer Identification Survey Competitive Landscape / M&A Feasibility www.emergenresearch.com
Industries We Cater to Food & Beverages Foods & Beverage, Food Ingredients, Food Processing and Equipment, Food Testing and Supply Chain, Health Food and Sports Nutrition, Frozen and Processed Food, Household, Retail Power & Energy Oil and Gas, Electricity, Energy Storage, Environmental, Renewable Energy Automotive Services Information and Tech Electric and Hybrid Vehicles, Off Highway and On Highway Vehicles, Aftermarket and Maintenance, Automotive Parts, Interior and Exterior Materials, Automotive electronics and Systems Data Security, Cloud Computing, IoT and Digitalization, Robotics, Telecom and Networking, Software and Services, Analytics, Semiconductor, Internet and E-Commerce www.emergenresearch.com Pharma & Healthcare Materials and Chemicals Medical Devices, Therapeutics, Biotechnology, Medical Imaging, Healthcare IT, Hospital Management, Diagnostics, Laboratory Equipment, Pharmaceutical Organic Chemicals, Disinfectants and Preservatives, Adhesives and Sealants, Polymers and Resins, Petrochemicals, Agrochemicals and Fertilizers, Paints and Coatings 5
Market Summary The global Next Generation Sequencing Market is expected to reach USD 23.59 Billion by 2027, according to a new report by Emergen Research. The benefits of high-performance sequencing compared to other generations, such as the sanger-seq and microarrays, are one of the main drivers of the Next Generation Sequencing (NGS) industry. Therefore, it is expected that the increased availability of low input DNA sampling methods would speed up the use of next-generation sequence across various clinical and research applications. New England Biolabs Technology that uses magnetic beads in the prototype assembly process is expected to boost next-generation sample preparedness protocols significantly. Moreover, the dropping costs and the added value of next-generation sequencing data relative to traditional data are anticipated to have a positive impact on this technology's diversification in other clinical areas and result in lucrative revenue growth. Recent developments in microfluidics and genetic sequencing equipment have paved the way for the creation of cost-effective, highly precise, and fast test platforms that can be used as POC systems. This is a major factor that contributes substantially to the well-funded, high growth potential of the next-generation sequencing market. Read More : https://www.emergenresearch.com/industry-report/next-generation-sequencing-market www.emergenresearch.com
Market Summary Some Key Highlights from the Report The oncology application for next-generation sequencing was estimated with the biggest share of revenues on the market. This can be because the technology has largely been used to decipher the connection between cancer and genetics. Due to its distinct advantages over the genome segment in terms of coverage scope and multiplexing capabilities, the targeted sequencing in the technology segment dominated the revenue share. Academic research held the largest market share of 53.9% in the year 2019, and these organizations are the key end-users for revenue generation because of the high penetration of research activities through seq-technology. This technology, on the other hand, is continuously growing in clinical and clinical research. The emergence of an integrated platform based in the USA has accounted for North America's highest revenue share. Asia-Pacific is projected to expand fastest as domestics in China are growing, along with molecular diagnostics. Asia-Pacific is anticipated to register a CAGR of 11.5% during the forecast period. Key participants include Deere & Company, Topcon Positioning Systems, Trimble, Inc., DeLaval, Antelliq, Heliospectra, Afimilk Ltd., InnovaSea Systems, AKVA group, and Nexus Corporation, among others. Request Free Sample @ https://www.emergenresearch.com/request-sample/8 www.emergenresearch.com
Market Summary Next Generation Sequencing Market on the basis of technology, workflow, application, end-use, and region: Technology Outlook (Revenue, USD Billion; 2017-2027) Whole Genome Sequencing Whole Exome Sequencing Targeted Sequencing & Resequencing Application Outlook (Revenue, USD Billion; 2017-2027) Clinical Investigation Oncology Reproductive Health HLA Typing/Immune System Monitoring Metagenomics, Epidemiology & Drug Development Agrigenomics & Forensics End-Use Outlook (Revenue, USD Billion; 2017-2027) Academic Research Clinical Research Hospitals & Clinics Pharma & Biotech Entities Request customization @ https://www.emergenresearch.com/request-for-customization/8
MARKETSEGMENTATION www.emergenresearch.com
Regional Share Dynamics www.emergenresearch.com
LATEST PUBLICATIONS Gut Microbiome Test Market https://www.emergenresearch.com/industry-report/gut-microbiome-test-market Ground Defense System Market https://www.emergenresearch.com/industry-report/ground-defense-system-market Human Microbiome Market https://www.emergenresearch.com/industry-report/human-microbiome-market Molecular Forensics Market https://www.emergenresearch.com/industry-report/molecular-forensics-market Automatic Weapons Market https://www.emergenresearch.com/industry-report/automatic-weapons-market Mobile C-Arms Market https://www.emergenresearch.com/industry-report/mobile-c-arms-market Gallium Nitride Market https://www.emergenresearch.com/industry-report/gallium-nitride-market www.emergenresearch.com
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade. Our expertise umbrellas the technological environment of all major industries, and our services help you map your actions to ensure optimal yield. Our analysts utilize their market proficiency to offer actionable insights that help our clients implement profitable strategies and optimize their return on investment. Our services are wide-ranging, right from technological environment analysis to technological profiling that highlights the existing opportunities in the market you can capitalize on to stay ahead of your competitors. About Us www.emergenresearch.com
Lets Talk; Contact Information Reach out to us and our Research Executives will ensure you get the report that meets all your requirements and address all your concerns. 14671 110 Avenue, Surrey, British Columbia, V3R2A9 www.emergenresearch.com www.emergenresearch.com sales@emergenresearch.com +1 (604) 757-9756